Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

VALERIO, Maria Rosaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.080
EU - Europa 6.035
AS - Asia 5.468
SA - Sud America 882
AF - Africa 122
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 22.597
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.819
SG - Singapore 1.991
RU - Federazione Russa 1.543
CN - Cina 1.277
IT - Italia 1.202
DE - Germania 781
BR - Brasile 687
FI - Finlandia 610
VN - Vietnam 535
HK - Hong Kong 534
UA - Ucraina 427
BD - Bangladesh 382
PL - Polonia 332
GB - Regno Unito 280
FR - Francia 230
IE - Irlanda 189
JP - Giappone 183
SE - Svezia 140
CA - Canada 136
IN - India 126
KR - Corea 100
AR - Argentina 86
MX - Messico 58
NL - Olanda 54
IQ - Iraq 53
TR - Turchia 50
BE - Belgio 45
AT - Austria 42
ES - Italia 40
UZ - Uzbekistan 29
RO - Romania 27
ZA - Sudafrica 25
PK - Pakistan 24
AE - Emirati Arabi Uniti 23
EC - Ecuador 23
IR - Iran 22
CO - Colombia 21
VE - Venezuela 19
GR - Grecia 17
ID - Indonesia 17
KE - Kenya 15
MA - Marocco 15
TN - Tunisia 15
CI - Costa d'Avorio 14
JM - Giamaica 14
DZ - Algeria 13
PY - Paraguay 13
SA - Arabia Saudita 13
CZ - Repubblica Ceca 12
MY - Malesia 12
PH - Filippine 12
CH - Svizzera 11
CL - Cile 11
NP - Nepal 11
EG - Egitto 10
HN - Honduras 10
KZ - Kazakistan 9
AL - Albania 8
LT - Lituania 8
PE - Perù 8
CR - Costa Rica 7
GE - Georgia 7
LB - Libano 7
RS - Serbia 7
UY - Uruguay 7
IL - Israele 6
JO - Giordania 6
BG - Bulgaria 5
BO - Bolivia 5
BY - Bielorussia 5
DO - Repubblica Dominicana 5
PA - Panama 5
TH - Thailandia 5
AU - Australia 4
AZ - Azerbaigian 4
BH - Bahrain 4
ET - Etiopia 4
EU - Europa 4
GT - Guatemala 4
NO - Norvegia 4
PR - Porto Rico 4
PS - Palestinian Territory 4
SY - Repubblica araba siriana 4
BZ - Belize 3
NG - Nigeria 3
NI - Nicaragua 3
OM - Oman 3
SV - El Salvador 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
DK - Danimarca 2
EE - Estonia 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
MD - Moldavia 2
MN - Mongolia 2
PT - Portogallo 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 22.569
Salva come PNG Salva come JPEG
Città #
Singapore 1.353
Ashburn 1.167
Fairfield 860
San Jose 735
Chandler 538
Hong Kong 514
Woodbridge 489
Wilmington 444
Houston 371
Ann Arbor 360
Seattle 343
Moscow 306
Zgierz 293
Cambridge 283
Jacksonville 231
Santa Clara 209
Beijing 205
Dublin 191
Ho Chi Minh City 175
Tokyo 172
Los Angeles 169
Medford 169
New York 166
Dallas 148
Council Bluffs 145
Des Moines 141
Palermo 141
Hefei 138
Hanoi 135
Lauterbourg 131
Frankfurt am Main 124
Princeton 107
Altamura 104
Nanjing 99
Boardman 96
The Dalles 95
Milan 86
Buffalo 85
Lawrence 79
São Paulo 73
Helsinki 72
Rome 71
Chicago 70
San Diego 60
Tulsa 58
Dearborn 56
Ludwigshafen am Rhein 53
London 48
Brussels 45
Nuremberg 41
Shenyang 39
Orem 38
Tianjin 38
Jinan 36
Venice 36
Hebei 35
Montreal 35
Seongnam 33
Munich 32
Seoul 30
Da Nang 29
Atlanta 27
Brooklyn 27
Nanchang 27
Rio de Janeiro 27
Falls Church 26
Lappeenranta 26
Columbus 25
Denver 25
Phoenix 25
Warsaw 25
Chennai 24
Stockholm 24
Vancouver 24
Changsha 23
Tashkent 23
Toronto 23
Berlin 22
Guangzhou 22
Jiaxing 22
Poplar 22
Baghdad 21
Haiphong 20
Kerken 20
Naples 20
Paris 20
Vienna 20
Amsterdam 19
Boston 19
Zhengzhou 19
San Francisco 18
Catania 17
Curitiba 17
Kumar 17
Memphis 17
Ningbo 17
Saint Petersburg 17
Washington 17
Redondo Beach 16
Ankara 15
Totale 13.460
Salva come PNG Salva come JPEG
Nome #
Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 341
Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients 319
Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 304
A phase II study of oxaliplatin (O) and gemcitabine (G) first line chemotherapy in patients with advanced biliary tract cancers 284
A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer. 283
Management of toxicities associated with targeted therapies for HR-positive metastatic breast cancer: a multidisciplinary approach is the key to success 279
A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma 277
Abemaciclib: safety and effectiveness of a unique cyclin-dependent kinase inhibitor 274
Clinical presentation and treatment of gastrointestinal stromal tumors. 271
TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma 264
The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers 264
Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 263
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study. 262
Gastric and Rectal Metastases from Malignant Melanoma Presenting with Hypochromic Anemia and Treated with Immunotherapy 260
Surviving Twenty Years to Bone and Liver Metastatic Breast Cancer: A Case Reported by Treating Oncologists and the Patient Herself 259
Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale 258
Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 254
L'impiego del Tachosil in chirurgia epatica 248
Adherence, compliance and persistence to oral antineoplastic therapy: A review focused on chemotherapeutic and biologic agents 243
Axillary Nodal Burden in Breast Cancer Patients With Pre-operative Fine Needle Aspiration-proven Positive Lymph Nodes Compared to Those With Positive Sentinel Nodes 224
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study 224
Alexithymia and coping style in women going to visit in a breast cancer center. 223
Safety and activity of trastuzumab-containing therapies for the treatment of metastatic breast cancer: our long-term clinical experience (GOIM study). 219
A Case of Follicular Tumor of Uncertain Malignant Potential (FT-UMP) with Glomeruloid Features Showing Capsular Mucinous Degeneration 219
A Practical Narrative Review on the Role of Magnesium in Cancer Therapy 216
Mutational analysis of BRCA1 gene in sicilian patients at risk for inherited breast and/or ovarian cancer: experience of reference centre for the biomolecular characterization of neoplasms and genetic screening of hereditary tumors. 216
A phase II study of capecitabine oxaliplatin chemotherapy in metastatic breast cancer patients pretreated with anthracyclines and taxanes 216
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 216
Detection and clinical relevance of free-circulating tumor DNA in blood of patients with colorectal cancer 214
Metastatic seeding of colon adenocarcinoma manifesting as synchronous breast and chest wall localization: report of a case. 214
Analysis of Ki-ras mutations in stage I rectal carcinomas and respective regional lymphonodes 211
Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers 209
A.Mutational analysis of BRCA1 in sicilian patients at risk for inherited of reference center for the biomolecular characterizaztion of neoplasm and genetic screening of hereditary tumors 203
Evaluation of predictive factors for i-CLARAS (intraoperative complications in laparoscopic renal and adrenal surgery): a multicentre international retrospective cohort study 198
Cigarette smoking habit does not reduce the benefit from first line trastuzumab-based treatment in advanced breast cancer patients 194
Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study. 192
Low dose oral chemotherapy for hormone refractory prostate carcinoma estramustine phosphate versus estramustine phosphate and etoposide. A Randomized phase II study of GSTU foundation 191
Cetuximab and gemcitabine in elderly or adult PS2 patients with advanced non-small-cell lung cancer: The cetuximab in advanced lung cancer (CALC1-E and CALC1-PS2) randomized phase II trials. 187
Effects of hypolipidemic and hypoglycemic agents on atherogenic small, dense LDL in Type 2 diabetes 186
Mutational analysis of BRCA1 gene in sicilian patient at risk for inherited breast and/or ovarian cancer: experience of reference center the biomolecular characterization of neoplasm and genetic screening of hereditary tumors. 185
Detection of free-circulating tumor DNA in plasma of patients with gastrointestinal cancer. 185
Metronomic chemotherapy (mCHT) in HER2-ve advanced breast cancer (ABC) patients (pts): What has changed over the time? Preliminary results of the VICTOR-6 study 184
Detection and clinical relevance of free-circulating tumor DNA in blood of patients with colorectal cancer. Proceeding of ICACT Fifteenth International Congress on Anticancer Treatment February 9th 12th 2004, Paris accepted for oral presentation 183
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 183
TP53 in gastric cancer: mutations in the l3 loop and LSH motif DNA-binding domains of TP53 predict poor outcome 183
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: The MITO-2 randomized phase III trial 182
Cardiotossicità e Cardioprotezione. 181
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study 177
Gastric metastasis from breast cancer 177
Abemaciclib-associated Diarrhea: An Exploratory Analysis of Real-life Data 177
TP53 mutations and S-Phase fraction are independent prognostic indicators in locally advanced laryngeal squamous cell carcinoma 176
A phase 2 study of Oxaliplatin ( O ) – Capecitabine( C ) chemotherapy in metastatic breast cancer ( MBC ) patients pretreated with Anthracyclines and taxanes VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004 176
Liposomal-encapsulated doxorubicin plus cyclophosphamide as first-line therapy in metastatic breast cancer: a phase II multicentric study 176
DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study 175
Current Role of Intraoperative Frozen Section Examination of Sentinel Lymph Node in Early Breast Cancer 174
Epirubicina (EPI ) e Docetaxel (DOC ) come chemioterapia primaria ( C P ) nel trattamento del carcinoma mammario localmente avanzato ( CMLA ). VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004 173
The prognostic role of TP53 mutations in advanced laryngeal squamous cell carcinoma (LSCC). 173
Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer 170
TP53 mutations are not prognostic independent indicators in bladder cancer. 169
Does Smoking Cessation at Primary Diagnosis Reduce the Recurrence Risk of Nonmuscle-Invasive Bladder Cancer? Results of a Prospective Study 167
Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study. 166
Alexithymia and copyng style in women going to visit in a breast cancer center 165
Metronomic Chemotherapy (mCHT) in HER2-ve Advanced Breast Cancer (ABC) Patients (PTS): When Care Objectives Meet Patients’ Need. Preliminary Results of the Victor-6 Study 165
DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical outcome in operable gastric carcinoma: Results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study 164
Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9) 164
Weekly Paclitaxel (T) and pegylated liposomal Doxorubicin (PLD) as first line treatment in metastatic breast cancer (MBC) patients.VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004 162
Pegylated Liposomal Doxorubicin and weekly paclitaxel as first line treatment in metastatic breast cancer 157
Studio di phase II: Docetaxel settimanale come seconda linea chemioterapia nel carcinoma prostatico avanzato. 156
The Use of Gemcitabine in heavily pretreted breast cancer patients 156
Italian Survey on adjuvant treatment of non-small cell lung cancer (ISA) 155
A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine 154
Hematologic toxicity of radium-223 in elderly patients with metastatic Castration Resistant Prostate Cancer: a real-life experience 154
RUOLO DELL’ECOCOLOR DOPPLER TISSUTALE NELLA VALUTAZIONE DELLA CARDIOTOSSICITÀ DA CHEMIOTERAPICI 151
Salvage Therapy With Oral Metronomic Cyclophosphamide and Methotrexate for Castration refractory Metastatic Adenocarcinoma of the Prostate Resistant to Docetaxel 148
Effects of the number of removed lymph nodes on survival outcome in patients with sentinel node-negative breast cancer 148
Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1-3 node-positive rapidly proliferating breast cancer 147
Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancer 147
Radium-223 treatment in castration resistant bone metastatic prostate cancer. Should be the primary tumor always treated? 146
Metronomic oral vinorelbine in patients with advanced non-small cell lung cancer progressing after nivolumab immunotherapy: a retrospective analysis 145
Correlation between sentinel lymph node biopsy and non-sentinel lymph node metastasis in patients with cN0 breast carcinoma: comparison of invasive ductal carcinoma and invasive lobular carcinoma 143
Comprehensive Axillary Management of Clinically Node-Positive (cN plus ) Breast Cancer Patients: A Narrative Review on Neoadjuvant Chemotherapy 142
GRUPPO ONCOLOGICO ITALIA MERIDIONALE. NOVEL ASSOCIATION WITH GEMCITABINE AND DOCETAXEL AS SALVAGE CHEMOTHERAPY IN METASTATIC BREAST CANCER PREVIOUSLY TREATED WITH ANTHRACYCLINES: RESULT OF A NULTICENTER PHASE II STUDY 141
NEPA as antiemetic prophylaxis after failure of 5HT3-RA plus dexamethasone in patients receiving carboplatin and gemcitabine chemotherapy: A monocentric real-life experience 140
TP53 Mutation in exon 5 and S-Phase Fraction but not Mutations in Ras gene family and DNA-ploidy are Indipendent prognostic indicators in Laryngeal Squamous Cell Carcinoma 139
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study 138
p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: A prospective study with a five-year follow-up 137
Stereotactic Radiotherapy in Early-Stage Breast Cancer in Neoadjuvant and Exclusive Settings: A Systematic Review 135
Relationship between the thymidylate synthase, p53 levels with the treatment by Cyclophosphamide, Metotrexate, 5-Fluorouracil chemotherapy (CMF) versus Docetaxel (TXT) in the locally advanced carcinoma of breast. 133
Novel association with gemcitabine and docetaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracyclines: results of a multicenter phase II study 130
Impressive objective response to nab-paclitaxel plus trastuzumab as fifth line therapy in aelderly her2-positive breast cancer patient 130
High-dose Radiotherapy for Oligo-progressive NSCLC Receiving EGFR Tyrosine Kinase Inhibitors: Real World Data 129
Stereotactic Radiotherapy for the Treatment of Patients With Oligo-progressive Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor: Data From the Real World 129
A Narrative Review of the Role of Immunotherapy in Metastatic Carcinoma of the Colon Harboring a BRAF Mutation 128
Accuracy and Outcomes of Sentinel Lymph Node Biopsy in Male with Breast Cancer: A Narrative Review and Expert Opinion 127
TP53 mutations are not prognostic indipendent indicators in bladder cancer 125
STUDIO DI FASE II: DOCETAXEL SETTIMANALE COME SECONDA LINEA CHEMIOTERAPICA NEL CARCINOMA PROSTATICO AVANZATO 121
Oral metronomic cyclophosphamide with and without methotrexate as palliative treatment for patients with metastatic breast carcinoma 121
A Prospective Observational Study on the Structuring Process and Implementation of a Large Regional, Inter-hospital, Virtual Multidisciplinary Tumor Board on Prostate Cancer 120
Abemaciclib pharmacology and interactions in the treatment of HR+/HER2− breast cancer: a critical review 120
Lapatinib activity in a patient with encephalic metastases from trastuzumab-resistant her-2 positive breast cancer 120
Totale 18.803
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.451
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.451
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.307 81 252 26 76 69 48 84 67 147 156 81 220
2022/20231.607 166 310 29 155 189 243 105 110 164 8 72 56
2023/2024987 41 127 80 72 62 138 181 55 25 19 58 129
2024/20252.704 71 198 249 205 119 80 191 189 188 312 293 609
2025/202610.120 677 416 632 731 980 1.284 1.229 1.015 783 1.077 596 700
2026/2027455 455 0 0 0 0 0 0 0 0 0 0 0
Totale 23.324